BSE Prices delayed by 5 minutes... << Prices as on Aug 04, 2025 >>   ABB  5092.5 ATS - Market Arrow  [-5.65]  ACC  1790.15 ATS - Market Arrow  [-0.22]  AMBUJA CEM  605.1 ATS - Market Arrow  [-0.64]  ASIAN PAINTS  2449.75 ATS - Market Arrow  [0.84]  AXIS BANK  1068.45 ATS - Market Arrow  [0.55]  BAJAJ AUTO  8184.55 ATS - Market Arrow  [1.79]  BANKOFBARODA  241.2 ATS - Market Arrow  [2.59]  BHARTI AIRTE  1915.05 ATS - Market Arrow  [1.59]  BHEL  241.4 ATS - Market Arrow  [4.23]  BPCL  317.85 ATS - Market Arrow  [0.08]  BRITANIAINDS  5785.2 ATS - Market Arrow  [-0.31]  CIPLA  1515.45 ATS - Market Arrow  [0.95]  COAL INDIA  374.75 ATS - Market Arrow  [0.63]  COLGATEPALMO  2253.45 ATS - Market Arrow  [-0.13]  DABUR INDIA  529.45 ATS - Market Arrow  [-0.82]  DLF  793.65 ATS - Market Arrow  [2.12]  DRREDDYSLAB  1225.4 ATS - Market Arrow  [0.48]  GAIL  174.65 ATS - Market Arrow  [0.20]  GRASIM INDS  2788.2 ATS - Market Arrow  [2.42]  HCLTECHNOLOG  1474.3 ATS - Market Arrow  [1.47]  HDFC BANK  1992.25 ATS - Market Arrow  [-0.99]  HEROMOTOCORP  4534.45 ATS - Market Arrow  [5.14]  HIND.UNILEV  2541.55 ATS - Market Arrow  [-0.38]  HINDALCO  687.7 ATS - Market Arrow  [2.31]  ICICI BANK  1463 ATS - Market Arrow  [-0.57]  INDIANHOTELS  749.45 ATS - Market Arrow  [1.16]  INDUSINDBANK  803.9 ATS - Market Arrow  [2.58]  INFOSYS  1480.35 ATS - Market Arrow  [0.66]  ITC LTD  416.65 ATS - Market Arrow  [0.04]  JINDALSTLPOW  980.5 ATS - Market Arrow  [3.75]  KOTAK BANK  1996.95 ATS - Market Arrow  [0.24]  L&T  3630.05 ATS - Market Arrow  [1.13]  LUPIN  1883 ATS - Market Arrow  [0.94]  MAH&MAH  3200 ATS - Market Arrow  [1.26]  MARUTI SUZUK  12363.85 ATS - Market Arrow  [0.52]  MTNL  45.38 ATS - Market Arrow  [-0.70]  NESTLE  2277.35 ATS - Market Arrow  [0.06]  NIIT  121.95 ATS - Market Arrow  [7.49]  NMDC  71.89 ATS - Market Arrow  [2.06]  NTPC  332.1 ATS - Market Arrow  [0.38]  ONGC  234.95 ATS - Market Arrow  [-0.80]  PNB  104.65 ATS - Market Arrow  [1.45]  POWER GRID  288 ATS - Market Arrow  [-1.10]  RIL  1411.3 ATS - Market Arrow  [1.27]  SBI  795.65 ATS - Market Arrow  [0.21]  SESA GOA  431.2 ATS - Market Arrow  [1.61]  SHIPPINGCORP  211.3 ATS - Market Arrow  [0.38]  SUNPHRMINDS  1641 ATS - Market Arrow  [0.73]  TATA CHEM  974.65 ATS - Market Arrow  [1.91]  TATA GLOBAL  1072 ATS - Market Arrow  [0.19]  TATA MOTORS  653.65 ATS - Market Arrow  [0.76]  TATA STEEL  159.6 ATS - Market Arrow  [4.31]  TATAPOWERCOM  387.05 ATS - Market Arrow  [-0.58]  TCS  3074.9 ATS - Market Arrow  [2.39]  TECH MAHINDR  1475.45 ATS - Market Arrow  [2.53]  ULTRATECHCEM  12252.85 ATS - Market Arrow  [1.22]  UNITED SPIRI  1339.55 ATS - Market Arrow  [1.30]  WIPRO  246.05 ATS - Market Arrow  [1.34]  ZEETELEFILMS  119.15 ATS - Market Arrow  [2.41]  

Suven Life Sciences Ltd.

Auditor Report

NSE: SUVENBE BSE: 530239ISIN: INE495B01038INDUSTRY: Medical Research Services

BSE   Rs 267.60   Open: 272.00   Today's Range 256.50
272.30
 
NSE
Rs 268.80
+2.00 (+ 0.74 %)
+1.25 (+ 0.47 %) Prev Close: 266.35 52 Week Range 102.70
303.00
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 6114.51 Cr. P/BV 31.58 Book Value (Rs.) 8.51
52 Week High/Low (Rs.) 300/103 FV/ML 1/1 P/E(X) 0.00
Bookclosure 02/08/2024 EPS (Rs.) 0.00 Div Yield (%) 0.00
Year End :2025-03 

Suven Life Sciences Limited

Report on the Standalone Ind AS Financial Statements Opinion

We have audited the accompanying Standalone Ind AS financial statements of Suven Life Sciences Limited ('the Company') which comprise the Balance Sheet as at 31st March, 2025, the Statement of Profit and Loss (including Other Comprehensive Loss), the Statement of Changes in Equity and the Statement of Cash Flows for the year ended on that date and notes to the Standalone Ind AS financial statements, including material accounting policies and other explanatory information (herein after referred to as "Standalone Ind AS financial statements").

In our opinion and to the best of our information and according to the explanations given to us, the aforesaid Standalone Ind AS financial statements give the information required by the Companies Act, 2013, as amended ("the Act") in the manner so required and give a true and fair view in conformity with the Indian Accounting Standards ("Ind AS") prescribed under section 133 of the Act read with the Companies (Indian Accounting Standards) Rules, 2015, as amended and other accounting principles generally accepted in India, of the state of affairs of the Company as at 31st March, 2025, its loss including other comprehensive loss, changes in equity and its cash flows for the year ended on that date.

Basis for Opinion

We conducted our audit of the Standalone Ind AS financial statements in accordance with the Standards on Auditing (SAs) specified under section 143(10) of the Act. Our responsibilities under those Standards are further described in the 'Auditor's Responsibilities for the Audit of the Standalone Ind AS Financial Statements' section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India (ICAI) together with the ethical requirements that are relevant to our audit of the Standalone Ind AS financial statements under the provisions of the Act and the Rules made thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the ICAI's Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion on the Standalone Ind AS financial statements.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the Standalone Ind AS financial statements for the financial year ended 31st March, 2025. These matters were addressed in the context of our audit of the Standalone Ind AS financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters. We have determined the matters described below to be the key audit matters to be communicated in our report.

S. No

Key Audit Matters

Auditor's Response

1

Investment in Subsidiary:

The carrying value of investment in the subsidiary as at 31st March, 2025 is C69,147.15 Lakhs.

This investment is reviewed at the end of each reporting period to determine whether there is any indication of impairment. If such evidence exists, impairment loss is determined and recognised in accordance with Note 2(n) of accounting policies to the Standalone Ind AS financial statements.

We have identified the assessment of impairment indicators and resultant provision, if any, in respect of investment in subsidiary as a key audit matter because of:

• The significance of the amount of this investment in the Standalone Balance Sheet.

• Performance and net worth of these entities and

• The degree of management judgement involved in determining the recoverable amount of these investments including:

-Valuation assumptions, such as discount rates.

- Business assumptions used by management, such as sales growth and costs and the resultant cash flows projected to be generated from these investments.

Our audit procedures in respect of impairment of investment in

subsidiary included the following:

• Testing design, implementation and operating effectiveness of key controls over the impairment review process including the review and approval of forecasts and review of valuation models;

• Assessing the valuation methodology used by management and management review control is around making the assessment and testing the mathematical accuracy of the impairment models;

• Evaluating the reasonableness of the valuation assumptions, such as discount rates, used by management through reference to external market data;

• Challenging the appropriateness of the business assumptions used by management, such as sales growth, cost and the probability of success of new molecules;

• Evaluating past performances where relevant and assessed historical accuracy of the forecast produced by management;

• Enquiring and challenging management on the commercial strategy associated with the products to ensure that it was consistent with the assumptions used in estimating future cash flows;

• Considering whether events or transactions that occurred after the balance sheet date but before the reporting date affect the conclusions reached and the associated disclosures; and

• Performing sensitivity analysis of key assumptions, including future revenue growth rates, costs and the discount rates applied in the valuation models.

2

Evaluation of going concern assumption of accounting

The evaluation of the appropriateness of the adoption of the going concern assumption for the preparation of these financial statements by the management of the Company has been identified as a key audit matter. This is due to the fact that, as at March 31, 2025, the Company has incurred continuous losses over the past five years. Management believes that anticipated net cash inflows from future fund-raising activities will provide sufficient liquidity to meet the Company's ongoing research and clinical trial expenditures. Accordingly, these financial statements have been prepared on a going concern basis.

Our audit procedures in respect of going concern assumption included

the following:

• Obtaining an understanding of the process followed by management for assessing going concern, including evaluating internal controls over the preparation of cash flow forecasts and validating the key assumptions and inputs used in the model

• Assessing the Company's funding strategy, including reviewing recent communications with existing and prospective investors, and examining proposed financing plans

• Evaluating management's historical ability to raise financing and reviewing any post-balance sheet events that may support or contradict the going concern assumption

• Assessing the adequacy and clarity of the related disclosures in the financial statements regarding the going concern basis of preparation and the associated material uncertainty.

3.

Revenue Recognition

Our audit procedures in respect of going concern assumption included

The Company earns revenue by providing analytical

the following:

services to pharmaceutical clients. Revenue is

• Understanding the revenue recognition process and tested key

recognised over time as the services are performed,

controls over contract review and timing of revenue recognition;

based on the progress of work under each contract.

• Reviewed a sample of customer contracts to evaluate how revenue

These contracts may include multiple stages or milestones.

was recognised based on contract terms;

• Tested how progress on contracts was measured and whether

Applying Ind AS 115 - Revenue from Contracts

revenue was recognised appropriately;

with Customers involves management judgment

• Checked sales recorded near year-end to ensure revenue was

in identifying performance obligations, choosing how to measure progress (such as time spent or

recognised in the correct period;

work completed), and deciding when to recognise

• Evaluated the financial statement disclosures for compliance with

revenue.

Due to the number of contracts, variation in terms, and the judgment required, we considered revenue recognition to be a key audit matter.

Ind AS 115.


Information Other than the Standalone Ind AS Financial Statements and Auditor's Report Thereon

The Company's Board of Directors is responsible for the preparation of the other information. The other information comprises the information included in the Management Discussion and Analysis, Board's Report including Annexures to Board's Report, Business Responsibility Report, Corporate Governance and Shareholder's Information, but does not include the consolidated Ind AS financial statements, Standalone Ind AS financial statements and our auditor's report thereon.

Our opinion on the Standalone Ind AS financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

In connection with our audit of the Standalone Ind AS financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the Standalone Ind AS financial statements or our knowledge obtained during the course of our audit or otherwise appears to be materially misstated.

If, based on the work we have performed, we conclude that there is a material misstatement of this other information; we are required to report that fact. We have nothing to report in this regard.

Responsibilities of Management and Those Charged with Governance for Standalone Ind AS Financial Statements

The Company's Board of Directors is responsible for the matters stated in section 134(5) of the Companies Act, 2013 ("the Act") with respect to the preparation of these Standalone Ind AS financial statements that give a true and fair view of the financial position, financial performance including other comprehensive loss, changes in equity and cash flows of the Company in accordance with the accounting principles generally accepted

in India, including the Indian Accounting Standards (Ind AS) specified under section 133 of the Act read with the Companies (Indian Accounting Standards) Rules, 2015, as amended.

This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the Standalone Ind AS financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the Standalone Ind AS financial statements, the Board of Directors is responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

Those Board of Directors are responsible for overseeing the Company's financial reporting process.

Auditor's Responsibility for the Audit of the Standalone Ind AS Financial Statements

Our objectives are to obtain reasonable assurance about whether these Standalone Ind AS financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise

from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Standalone Ind AS financial statements.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

• Identify and assess the risks of material misstatement of the Standalone Ind AS financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

• Obtain an understanding of internal financial controls relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under section 143(3)(i) of the Act, we are also responsible for expressing our opinion on whether the Company has adequate internal financial controls system in place and the operating effectiveness of such controls.

• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

• Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the Standalone Ind AS financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.

• Evaluate the overall presentation, structure and content of the Standalone Ind AS financial statements, including the disclosures, and whether the Standalone Ind AS financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

Materiality is the magnitude of misstatements in the Standalone Ind AS financial statements that, individually or in aggregate, makes it probable that the economic decisions of a reasonably knowledgeable user of the Standalone Ind AS financial statements

may be influenced. We consider quantitative materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to evaluate the effect of any identified misstatements in the Standalone Ind AS financial statements.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the Standalone Ind AS financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor's report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

Report on Other Legal and Regulatory Requirements

As required by the Companies (Auditor's Report) Order, 2020 ("the Order"), issued by the Central Government of India in terms of subsection (11) of section 143 of the Act, we give in the “Annexure-A", a statement on the matters specified in paragraphs 3 and 4 of the Order, to the extent applicable.

As required by section 143 (3) of the Act, based on our audit we report that:

a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purposes of our audit.

b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books except for the matters stated in paragraph 143(3)(h)(vi) below on reporting under Rule 11(g) of the Companies (Audit and Auditors) Rules, 2014.

c) The Balance Sheet, the Statement of Profit and Loss including Other Comprehensive Loss, Statement of Changes in Equity and the Statement of Cash Flows dealt with by this Report are in agreement with the books of account.

d) In our opinion, the aforesaid Standalone financial statements comply with the Indian Accounting Standards specified under Section 133 of the Act, read with Companies (Indian Accounting Standards) Rules, 2015, as amended.

e) On the basis of the written representations received from the directors as on 31st March, 2025, taken on record by the Board of Directors, none of the directors is disqualified as on 31st March, 2025, from being appointed as a director in terms of Section 164(2) of the Act.

f) With respect to the adequacy of the internal financial controls over financial reporting of the Company and the operating effectiveness of such controls, refer to our separate report in “Annexure-B". Our report expresses an unmodified opinion on the adequacy and operating effectiveness of the Company's internal financial controls over financial reporting.

g) With respect to the other matters to be included in the Auditor's Report in accordance with the requirements of section 197(16) of the Act, as amended:

In our opinion and to the best of our information and according to the explanations given to us, the remuneration paid by the Company to its directors during the year is in accordance with the provisions of section 197 of the Act.

h) With respect to the other matters to be included in the Auditor's Report in accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2014, as amended, in our opinion and to the best of our information and according to the explanations given to us:

i. The Company has disclosed the impact of pending litigations on its financial position in its Standalone Ind AS financial statements- Refer Note 29 to the Standalone Ind AS financial statements

ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses.

iii. There has been no delay in transferring amounts, required to be transferred, to the Investor Education and Protection Fund by the Company.

iv. a) The management has represented that, to the

best of its knowledge and belief, no funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other person or entity, including

foreign entities ("Intermediaries"), with the understanding, whether recorded in writing or otherwise, that the Intermediaries shall, whether, directly or indirectly lend or invest in other person or entity identified in any manner whatsoever by or on behalf of the Company ("Ultimate Beneficiaries") or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries;

b) The management has represented that, to the best of its knowledge and belief, no funds have been received by the Company from any person or entity, including foreign entities ("Funding Parties"), with the understanding, whether recorded in writing or otherwise, that the Company shall, whether, directly or indirectly, lend or invest in other person or entity identified in any manner whatsoever by or on behalf of the Funding Parties ("Ultimate Beneficiaries") or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries; and

c) Based on the audit procedures that were considered reasonable and appropriate in the circumstances, nothing has come to our notice that has caused us to believe that the representations under sub-clause (a) and (b) contain any material misstatement.

v. No dividend has been declared or paid during the year by the Company.

vi. The reporting under Rule 11(g) of the Companies (Audit and Auditors) Rules, 2014 is applicable from 1st April, 2023.

Based on our examination which included test checks, except for the instances mentioned below, the Company has used accounting software for maintaining its books of account, which has a feature of recording audit trail (edit log) facility and the same has operated throughout the year for all relevant transactions recorded in the software except in the case of records of property, plant and equipment and payroll which are being maintained manually.

For KARVY & CO.,

Chartered Accountants ICAI Firm Regn. No.001757S

AJAYKUMAR KOSARAJU

Partner

Place: Hyderabad Membership No.021989

Date: May 13th ,2025 UDIN: 25021989BMIARX3916

 
STOCKS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z|Others

Mutual Fund A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

Registered Office : 402, Nirmal Towers, Dwarakapuri Colony, Punjagutta, Hyderabad - 500082.
SEBI Registration No's: NSE / BSE / MCX : INZ000166638. Depository Participant: IN- DP-224-2016.
AMFI Registered Number - 29900 (ARN valid upto 24th July 2025) - AMFI-Registered Mutual Fund Distributor since June 2008.
Compliance Officer :- Name: Ch.V.A. Varaprasad, Mobile No.: 9393136201, E-mail: varaprasad.challa@rlpsec.com
Grievance Cell: rlpsec_grievancecell@yahoo.com , rlpdp_grievancecell@yahoo.com
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
Copyrights @ 2014 © RLP Securities. All Right Reserved Designed, developed and content provided by